Susan Calcaterra, MD, MPH/MSPH, MS

Associate Professor, Medicine-Hospital Medicine

FacultyPhoto
Medical School
  • MD, Wayne State University School of Medicine (2007)
Graduate Schools
  • MS, Wayne State University (2002)
  • MPH, University of Colorado Health Sciences Center (2012)
Undergraduate School
  • BA, University of Michigan (MI) (1999)
Internship
  • University of Colorado (University Hospital) Program (2008)
Residency
  • University of Colorado (University Hospital) Program, Internal Medicine (2010)
Fellowships
  • University of Colorado (University Hospital) Program, Addiction Medicine Fellowship Program (2018)
  • University of Colorado, Primary Care Research Fellowship (2012)
Languages
English
Department
Medicine-Hospital Medicine

Professional Titles

  • Director, Addiction Medicine Consultation Liaison Service
  • Associate Program Director, Addiction Medicine Fellowship

Publications

  • Herzig SJ, Mosher HJ, Calcaterra SL, Nuckols TK. Reply to "In Reference to 'Improving the Safety of Opioid Use for Acute Noncancer Pain in Hospitalized Adults: A Consensus Statement from the Society of Hospital Medicine'". J Hosp Med. 2018 Sep;13(10):728. PubMed PMID: 30261091
  • Herzig SJ, Mosher HJ, Calcaterra SL, Jena AB, Nuckols TK. Improving the Safety of Opioid Use for Acute Noncancer Pain in Hospitalized Adults: A Consensus Statement From the Society of Hospital Medicine. J Hosp Med. 2018 Apr;13(4):263-271. PubMed PMID: 29624189
  • Herzig SJ, Calcaterra SL, Mosher HJ, Ronan MV, Groningen NV, Shek L, Loffredo A, Keller M, Jena AB, Nuckols TK. Safe Opioid Prescribing for Acute Noncancer Pain in Hospitalized Adults: A Systematic Review of Existing Guidelines. J Hosp Med. 2018 Apr;13(4):256-262. PubMed PMID: 29624188
  • Calcaterra SL, Severtson SG, Bau GE, Margolin ZR, Bucher-Bartelson B, Green JL, Dart RC. Trends in intentional abuse or misuse of benzodiazepines and opioid analgesics and the associated mortality reported to poison centers across the United States from 2000 to 2014. Clin Toxicol (Phila). 2018 Nov;56(11):1107-1114. PubMed PMID: 29609498
  • Calcaterra SL, Scarbro S, Hull ML, Forber AD, Binswanger IA, Colborn KL. Prediction of Future Chronic Opioid Use Among Hospitalized Patients. J Gen Intern Med. 2018 Jun;33(6):898-905. PubMed PMID: 29404943
  • Glanz JM, Narwaney KJ, Mueller SR, Gardner EM, Calcaterra SL, Xu S, Breslin K, Binswanger IA. Prediction Model for Two-Year Risk of Opioid Overdose Among Patients Prescribed Chronic Opioid Therapy. J Gen Intern Med. 2018 Oct;33(10):1646-1653. PubMed PMID: 29380216
  • Kennedy LC, Binswanger IA, Mueller SR, Levy C, Matlock DD, Calcaterra SL, Koester S, Frank JW. "Those Conversations in My Experience Don't Go Well": A Qualitative Study of Primary Care Provider Experiences Tapering Long-term Opioid Medications. Pain Med. 2018 Nov 1;19(11):2201-2211. PubMed PMID: 29126138
  • Terasaki D, Smith C, Calcaterra SL. Transitioning Hospitalized Patients with Opioid Use Disorder from Methadone to Buprenorphine without a Period of Opioid Abstinence Using a Microdosing Protocol. Pharmacotherapy. 2019 Oct;39(10):1023-1029. PubMed PMID: 31348544
  • Binswanger IA, Narwaney KJ, Gardner EM, Gabella BA, Calcaterra SL, Glanz JM. Development and evaluation of a standardized research definition for opioid overdose outcomes. Subst Abus. 2019;40(1):71-79. PubMed PMID: 30875477
  • Calcaterra SL, Bach P, Chadi A, Chadi N, Kimmel SD, Morford KL, Roy P, Samet JH. Methadone Matters: What the United States Can Learn from the Global Effort to Treat Opioid Addiction. J Gen Intern Med. 2019 Jun;34(6):1039-1042. PubMed PMID: 30729416
  • Calcaterra SL, Hopfer CJ, Keniston A, Hull ML. Changes in Healthcare Encounter Rates Possibly Related to Cannabis or Alcohol following Legalization of Recreational Marijuana in a Safety-Net Hospital: An Interrupted Time Series Analysis. J Addict Med. 2019 May Jun;13(3):201-208. PubMed PMID: 30475257
  • Yogo N, Shihadeh K, Young H, Calcaterra SL, Knepper BC, Burman WJ, Mehler PS, Jenkins TC. Intervention to Reduce Broad-Spectrum Antibiotics and Treatment Durations Prescribed at the Time of Hospital Discharge: A Novel Stewardship Approach. Infect Control Hosp Epidemiol. 2017 May;38(5):534-541. PubMed PMID: 28260538
  • Calcaterra SL, Drabkin AD, Doyle R, Leslie SE, Binswanger IA, Frank JW, Reich JA, Koester S. A Qualitative Study of Hospitalists' Perceptions of Patient Satisfaction Metrics on Pain Management. Hosp Top. 2017 Jan-Mar;95(1):18-26. PubMed PMID: 28362247
  • Calcaterra SL, Yamashita TE, Min SJ, Keniston A, Frank JW, Binswanger IA. Opioid Prescribing at Hospital Discharge Contributes to Chronic Opioid Use. J Gen Intern Med. 2016 May;31(5):478-85. PubMed PMID: 26553336
  • Frank JW, Levy C, Matlock DD, Calcaterra SL, Mueller SR, Koester S, Binswanger IA. Patients' Perspectives on Tapering of Chronic Opioid Therapy: A Qualitative Study. Pain Med. 2016 Oct;17(10):1838-1847. PubMed PMID: 27207301
  • Ritvo AD, Calcaterra SL, Ritvo JI. Using Extended Release Buprenorphine Injection to Discontinue Sublingual Buprenorphine: A Case Series. J Addict Med. 2020 Sep 10. [Epub ahead of print] PubMed PMID: 32925232
  • Joudrey PJ, Chadi N, Roy P, Morford KL, Bach P, Kimmel S, Wang EA, Calcaterra SL. Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: A cross-sectional study. Drug Alcohol Depend. 2020 Mar 27;211:107968. [Epub ahead of print] PubMed PMID: 32268248
  • Calcaterra SL, Klie KA. Methadone, Buprenorphine, or Detoxification for Management of Perinatal Opioid Use Disorder: A Cost-Effectiveness Analysis. Obstet Gynecol. 2020 Apr;135(4):975. PubMed PMID: 32217961
  • Frank JW, Levy C, Calcaterra SL, Hoppe JA, Binswanger IA. Naloxone Administration in US Emergency Departments, 2000-2011. J Med Toxicol. 2016 Jun;12(2):148-56. PubMed PMID: 26621354
  • Calcaterra SL, Drabkin AD, Leslie SE, Doyle R, Koester S, Frank JW, Reich JA, Binswanger IA. The hospitalist perspective on opioid prescribing: A qualitative analysis. J Hosp Med. 2016 Aug;11(8):536-42. PubMed PMID: 27157317
  • Calcaterra SL, Lou Y, Everhart RM, Fish LE, Hanratty R. Association Between In-Clinic Opioid Administration and Discharge Opioid Prescription in Urgent Care: a Retrospective Cohort Study. J Gen Intern Med. 2021 Jan;36(1):43-50. PubMed PMID: 32728954
  • Calcaterra SL, Burnett-Hartman AN, Powers JD, Corley DA, McMullen CM, Pawloski PA, Feigelson HS. A population-based survey to assess the association between cannabis and quality of life among colorectal cancer survivors. BMC Cancer. 2020 May 3;20(1):373. PubMed PMID: 32362277
  • Frank JW, Binswanger IA, Calcaterra SL, Brenner LA, Levy C. Non-medical use of prescription pain medications and increased emergency department utilization: Results of a national survey. Drug Alcohol Depend. 2015 Dec 1;157:150-7. PubMed PMID: 26564754
  • Calcaterra SL, Binswanger IA, Edelman EJ, McNair BK, Wakeman SE, O'Connor PG. The impact of access to addiction specialist on attitudes, beliefs and hospital-based opioid use disorder related care: A survey of hospitalist physicians. Subst Abus. 2020 Apr 8;:1-9. [Epub ahead of print] PubMed PMID: 32267807
  • Calcaterra SL, Cunningham CO, Hopfer CJ. The Void in Clinician Counseling of Cannabis Use. J Gen Intern Med. 2020 Jun;35(6):1875-1878. PubMed PMID: 31898125
  • Mueller SR, Walley AY, Calcaterra SL, Glanz JM, Binswanger IA. A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice. Subst Abus. 2015;36(2):240-53. PubMed PMID: 25774771
  • Calcaterra SL, Keniston A, Blum J, Crume T, Binswanger IA. The Association Between Stimulant, Opioid, and Multiple Drug Use on Behavioral Health Care Utilization in a Safety-Net Health System. Subst Abus. 2015;36(4):407-12. PubMed PMID: 25738222
  • Calcaterra SL, Beaty B, Mueller SR, Min SJ, Binswanger IA. The association between social stressors and drug use/hazardous drinking among former prison inmates. J Subst Abuse Treat. 2014 Jul;47(1):41-9. PubMed PMID: 24642070
  • Calcaterra SL, Grimm E, Keniston A. External validation of a model to predict future chronic opioid use among hospitalized patients. J Hosp Med. 2022 Dec 16. [Epub ahead of print] PubMed PMID: 36524583
  • Calcaterra SL, Bottner R, Martin M, Englander H, Weinstein ZM, Weimer MB, Lambert E, Ronan MV, Huerta S, Zaman T, Ullal M, Peterkin AF, Torres-Lockhart K, Buresh M, O'Brien MT, Snyder H, Herzig SJ. Management of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: A systematic review of existing guidelines. J Hosp Med. 2022 Sep;17(9):679-692. PubMed PMID: 35880821
  • Calcaterra SL, Martin M, Bottner R, Englander H, Weinstein Z, Weimer MB, Lambert E, Herzig SJ. Management of opioid use disorder and associated conditions among hospitalized adults: A Consensus Statement from the Society of Hospital Medicine. J Hosp Med. 2022 Sep;17(9):744-756. PubMed PMID: 35880813
  • Bredenberg E, Hanna RM, Kotwas M, Singh S, Calcaterra SL. Inequities in treatment of substance use disorders among people with limited English proficiency. J Hosp Med. 2022 Jul;17(7):569-571. PubMed PMID: 35451241
  • Hoover K, Lockhart S, Callister C, Holtrop JS, Calcaterra SL. Experiences of stigma in hospitals with addiction consultation services: A qualitative analysis of patients' and hospital-based providers' perspectives. J Subst Abuse Treat. 2022 Jul;138:108708. PubMed PMID: 34991950
  • Calcaterra SL, Lockhart S, Callister C, Hoover K, Binswanger IA. Opioid Use Disorder Treatment Initiation and Continuation: a Qualitative Study of Patients Who Received Addiction Consultation and Hospital-Based Providers. J Gen Intern Med. 2022 Aug;37(11):2786-2794. PubMed PMID: 34981359
  • Callister C, Lockhart S, Holtrop JS, Hoover K, Calcaterra SL. Experiences with an addiction consultation service on care provided to hospitalized patients with opioid use disorder: a qualitative study of hospitalists, nurses, pharmacists, and social workers. Subst Abus. 2022;43(1):615-622. PubMed PMID: 34666634
  • Calcaterra SL, Butler M, Olson K, Blum J. The Impact of a PDMP-EHR Data Integration Combined With Clinical Decision Support on Opioid and Benzodiazepine Prescribing Across Clinicians in a Metropolitan Area. J Addict Med. 2022 May-Jun 01;16(3):324-332. PubMed PMID: 34392255
  • Calcaterra SL, McBeth L, Keniston AM, Burden M. The Development and Implementation of a Hospitalist-Directed Addiction Medicine Consultation Service to Address a Treatment Gap. J Gen Intern Med. 2022 Apr;37(5):1065-1072. PubMed PMID: 34013473
  • Awadallah NS, Rollins V, Oung AB, Dickinson M, de la Cerda D, Calcaterra S, Orr J, Grushan M. An Interprofessional Approach to Chronic Pain Management and Education. Fam Med. 2022 Jan;54(1):47-53. PubMed PMID: 35006600
  • Terasaki D, Kulick B, Calcaterra S, Ray L. Phenobarbital for alcohol withdrawal in the context of the opioid epidemic: a neglected caveat. Addiction. 2023 Jul;118(7):1198-1200. PubMed PMID: 36967706
  • Englander H, Priest KC, Snyder H, Martin M, Calcaterra S, Gregg J. A Call to Action: Hospitalists' Role in Addressing Substance Use Disorder. J Hosp Med. 2020 Mar;15(3):184-187. PubMed PMID: 31634100
  • Calcaterra S, Glanz J, Binswanger IA. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009. Drug Alcohol Depend. 2013 Aug 1;131(3):263-70. PubMed PMID: 23294765
  • Calcaterra S, Binswanger IA. National trends in psychostimulant-related deaths: 1999-2009. Subst Abus. 2013;34(2):129-36. PubMed PMID: 23577906
  • Calcaterra S, Blatchford P, Friedmann PD, Binswanger IA. Psychostimulant-related deaths among former inmates. J Addict Med. 2012 Jun;6(2):97-105. PubMed PMID: 22134174
  • Bove SE, Calcaterra SL, Brooker RM, Huber CM, Guzman RE, Juneau PL, Schrier DJ, Kilgore KS. Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis. Osteoarthritis Cartilage. 2003 Nov;11(11):821-30. PubMed PMID: 14609535
  • Bredenberg E, Tietbohl C, Dafoe A, Thurman L, Calcaterra S. Identifying factors that contribute to burnout and resilience among hospital-based addiction medicine providers: A qualitative study. J Subst Abuse Treat. 2023 Jan;144:108924. PubMed PMID: 36327617
  • Jawa R, Tin Y, Nall S, et al. Estimated Clinical Outcomes and Cost-effectiveness Associated With Provision of Addiction Treatment in US Primary Care Clinics. JAMA Netw Open. 2023;6(4):e237888. doi:10.1001/jamanetworkopen.2023.7888
  • Calcaterra SL, Martin M, Englander H. Identifying Barriers to OUD Treatment Linkage From the Emergency Department to the Community. JAMA Netw Open. 2023 May 1;6(5):e2312683. PubMed PMID: 37163270
  • Martin M, Englander H, Calcaterra SL. Things We Do for No Reason™: Avoiding methadone for opioid withdrawal. J Hosp Med. 2023 May 27. doi: 10.1002/jhm.13138. Epub ahead of print. PMID: 37244869.
  • Calcaterra SL, Lockhart S, Natvig C, Mikulich S. Barriers to initiate buprenorphine and methadone for opioid use disorder treatment with postdischarge treatment linkage. J Hosp Med. 2023 Aug 22. [Epub ahead of print] PubMed PMID: 37608527
  • Calcaterra SL, Saunders S, Grimm E, Maki-Gianani E, Keniston A, Wold A, Bonaguidi A. In-Hospital Methadone Enrollment: a Novel Program to Facilitate Linkage from the Hospital to the Opioid Treatment Program for Vulnerable Patients with Opioid Use Disorder. J Gen Intern Med. 2023 Sep 15. [Epub ahead of print] PubMed PMID: 37715094
  • Calcaterra SL, Buresh M, Weimer MB. Better care at the bedside for hospitalized patients with opioid use disorder. J Hosp Med. 2023 Apr 4. [Epub ahead of print] PubMed PMID: 37016586
  • Calcaterra SL, Peterkin AF. Antiracist Strategies to Combat Racial Disparities in the Delivery of Hospital-Based Addiction Care. J Gen Intern Med. 2023 Oct 17. [Epub ahead of print] PubMed PMID: 37848761
  • Stern SJ, D'Orazio JL, Work BD, Calcaterra SL, Thakrar AP. Point/counterpoint: Should full agonist opioid medications be offered to hospitalized patients for management of opioid withdrawal?. J Hosp Med. 2024 Apr;19(4):339-343. PubMed PMID: 38030816
  • Martin M, Englander H, Calcaterra SL. Things We Do for No Reason™: Avoiding methadone for opioid withdrawal. J Hosp Med. 2023 Nov;18(11):1034-1037. PubMed PMID: 37244869
  • Calcaterra SL, Dafoe A, Tietbohl C, Thurman L, Bredenberg E. Unintended consequences of methadone regulation for opioid use disorder treatment among hospitalized patients. J Hosp Med. Published online March 20, 2024. doi:10.1002/jhm.13329
  • Sandhu S, Calcaterra SL. Curbside Consult: How do I manage acute pain for patients prescribed buprenorphine for opioid use disorder? NEJM Evidence. April 23, 2024. DOI: 10.1056/EVIDccon2300275
  • Callister C, Porter S, Vatterott P, Keniston A, McBeth L, Mann S, Calcaterra SL, Limes J. The Impact of Completing X-Waiver Training and Clinical Addiction Exposure on Internal Medicine Residents Treating Patients With Opioid Use Disorder. Subst Use Addctn J. 2024 Jul;45(3):356-366. PubMed PMID: 38258815
  • Calcaterra SL, Yamkovoy K, Swathi PA, Ciccarone D, Del Pozo B, Englander H, Wang J, Barocas JA. U.S. trends in methamphetamine-involved psychiatric hospitalizations in the United States, 2015-2019. Drug Alcohol Depend. 2024 Jul 28;262:111409. [Epub ahead of print] PubMed PMID: 39089187
  • Bredenberg E, Callister C, Dafoe A, Holliman BD, Rowan SE, Calcaterra SL. Subspecialty physicians' perspectives on barriers and facilitators of hepatitis C treatment: a qualitative study. Harm Reduct J. 2024 Jul 25;21(1):140. PubMed PMID: 39054530

Professional Memberships

  • Society of General Internal Medicine, member
  • Society of Hospital Medicine, member

Practice Locations

UCHealth Internal Medicine - Anschutz Medical Campus
1635 Aurora Ct
5th Floor
Aurora, CO 80045
720-848-2300

Hospital Affiliation
  • University of Colorado Hospital


School of Medicine

CU Anschutz
Fitzsimons Building

13001 East 17th Place

Aurora, CO 80045

303.724.5375

School
General
Students